Fiche centre
Investigational Site Number : 5280001
Amsterdam — Netherlands
Essais liés2clinical trials
VilleAmsterdamlocalisation
PaysNetherlandslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03996291
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Tolebrutinib | SEP | Phase 3 | NCT06372145 | A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. | ACTIVE_NOT_RECRUITING |
| Tolebrutinib | SEP | Phase 2 | NCT03996291 | Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis | COMPLETED |